Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

NLRP3-IN-12

Cat. No.: IBDI-431456

NLRP3-IN-12 is a specific NLRP3 inflammasome inhibitor. NLRP3-IN-12 reduces the release of IL-1β by targeting the NLRP3 protein, with an IC50 of 0.45 μM. NLRP3-IN-12 can be used for the research of inflammatory bowel disease.

Size (Solid):

Product Details

Target NOD-like Receptor (NLR)
Molecular Weight 518.00
SMILES O[[email protected]@H]1[[email protected]]2(CO3)[[email protected]@]([[email protected]](O)[[email protected]]3(O)[[email protected]]45[[email protected]@]2([H])CC[[email protected]](C(C5=O)=C)([H])[[email protected]@]4([H])OC(NC6=CC=CC(Cl)=C6)=O)([H])C(C)(C)CC1

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.